Pulmonary Embolism in Outpatient Practice: Frequency and Risk Factors

The regional features of the frequency of thromboembolic complications and the structure of risk factors in outpatient practice were investigated. Gender and age analysis showed the prevalence of males aged 80 years and older. Cardiac arrhythmias and chronic heart failure had the greatest share in the risk factors for PE.

1. Barbarabash O. L., Bojtsov S. A., Vajsman D. Sh. i dr. Problemy otsenki pokazatelej smertnosti ot otdel'nykh prichin position statement. Kompleksnye Problemy Serdechno-Sosudistykh Zabolevanij. 2018; 7 (2): 6–9. doi: https://doi.org/10/17802/2306-1278-2018-7-2-6-9. (in Russian)

2. Vorob'eva N. M., Panchenko E. P. Antikoagulyantnaya terapiya venoznykh tromboembolicheskikh oslozhnenij: problemy i perspektivy. RKZh. 2015; 3 (119): 7–17. (in Russian)

3. Nikulina N. N., Terekhovskaya Yu.V. Epidemiologiya tromboembolii legochnoj arterii v sovremennom mire: analiz zabolevaemosti, smertnosti i problem ikh izucheniya Rossijskij Kardiologicheskij Zhurnal. doi: http://dx.doi.org/10.15829/1560-4071-2019-6-103-108. (in Russian)

4. Podlipaeva A. A., Mullova I. S., Pavlova T. V., Ushakova E. V., Duplyakov D. V. Novye biologicheskie markery diagnostiki i prognozirovaniya riska smerti u patsientov s tromboemboliej legochnoj arterii. Rossijskij Kardiologicheskij Zhurnal. 2020; 25 (4): 38–45. doi: https://doi.org/10.15829/1560-4071-2020-4202. (in Russian)

5. Sulimov V. A., Napalkov D. A., Sokolova A. A., Zhilenko A. V., Anikina O. S. Antikoagulyantnaya terapiya v real'noj klinicheskoj praktike: dannye retrospektivnogo odnomomentnogo issledovaniya. Ratsional'naya Farmakoterapiya v Kardiologii. 2015; 11 (2): 116–123. (in Russian)

6. Informatsionno-metodicheskoe pis'mo Minzdrava Ryazanskoj oblasti № VKh/11-9587 ot 22.06.2023 «O meropriyatiyakh po uluchsheniyu kachestva okazaniya meditsinskoj pomoshchi patsientam s tromboemboliej legochnoj arterii». (in Russian)

7. Sokolova A. A., Tsarev I. L., Napalkov D. A., Sulimov V. A. Antikoagulyantnaya terapiya u patsientov s fibrillyatsiej predserdij: sostoyanie problemy v rutinnoj klinicheskoj praktike. Trudnyj Patsient. 2015; 13 (7): 36–40. (in Russian)

8. Krutman M., Wolosker N., Kuzniec S., de Campos Guerra J. C., Tachibana A., de Almeida Mendes C. Risk of asymptomatic pulmonary embolism in patients with deep venous thrombosis. J Vasc Surg Venous Lymphat Disord. 2013; 1 (4): 370–375. doi: 10.1016/j.jvsv.2013.04.002.

9. Bojtsov S. A., Nikulina N. N., Yakushin S. S., Furmenko G. I. Patologo-anatomicheskoe issledovanie v analize smertnosti naseleniya ot serdechno-sosudistykh zabolevanij. Arkhiv Patologii. 2011; 73 (1): 30–3. (in Russian)

10. Anderson F. A., Wheeler H. B., Goldberg R. J., Hosmer D. W., Patwardhan N. A., Jovanovic B., Forcier A., Dalen J. E. A population-based perspective of the hospital incidence and case-fatality rates of deep vein thrombosis and pulmonary embolism. Arch Intern Med. 1991; 151 (5): 933–8.

11. Spencer F. A., Lessard D., Emery C., Read G., Goldberg R. Venous thromboembolism in the outpatient setting. Arch Intern Med. 2007; 167 (14): 1471–1475. doi: 10.1001/archinte.167.14.1471.

12. Kalinina A. M., Kontsevaya A. V., Deev A. D. Dolgosrochnaya ekonomicheskaya effektivnost' programmy mnogofaktornoj profilaktiki serdechnososudistykh zabolevanij v pervichnoj mediko-sanitarnoj pomoshchi. Kardiovaskulyarnaya Terapiya i Profilaktika. 2013; 12 (1): 60–66. (in Russian)

13. Puurunen M. K., Gona P. N., Larson M. G., Murabito J. M., Magnani J. W., O'Donnell C. J. Epidemiology of venous thromboembolism in the Framingham Heart Study. Thromb Res. 2016; 145: 27–33. doi: 10.1016/j.thromres.2016.06.033.

14. Laporte S., Mismetti P., Décousus H., Uresandi F., Otero R., Lobo J. L., Monreal M.; RIETE Investigators. Clinical predictors for fatal pulmonary embolism in 15,520 patients with venous thromboembolism: findings from the Registro Informatizado de la Enfermedad TromboEmbolica venosa (RIETE) Registry. Circulation. 2008; 117 (13): 1711–1716. doi: 10.1161/CIRCULATIONAHA.107.726232.